[1]
J. Djuretić and B. Bufan, “Safety and efficacy of interleukin inhibitors in elderly patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis”, arhfarm, vol. 71, no. Notebook 2, pp. 101–119, Apr. 2021, doi: 10.5937/arhfarm71-30505.